The Indian Pharmacopoeia Commission (IPC), serving as the National Coordination Centre for the Pharmacovigilance Programme of India (NCCPvPI), inaugurated the 5th National Pharmacovigilance Week (NPW) on September 17, 2025, at the Bharat Mandapam Convention Centre in New Delhi. The NPW, observed from September 17-23, 2025, focuses on patient safety and adverse drug reaction (ADR) reporting, under the theme "Your Safety, Just a Click Away: Report to PvPI."
Drugs Controller General of India (DCGI), Dr. Rajeev Singh Raghuvanshi, emphasized the importance of pharmacovigilance and the need for increased patient participation in ADR reporting. He highlighted India's position as a top global contributor in adverse event reporting, while also noting the underutilization of available data.
The IPC launched several initiatives during the event, including a short film on PvPI, a pharmacovigilance comic in multiple vernacular languages, and a new online ADR reporting platform accessible via QR code. Awards were presented to recognize contributions in pharmacovigilance, including the PvPI Patient Safety Excellence Award to the ADR Monitoring Centre at Mahamana Pandit Madan Mohan Malviya Cancer Centre, Varanasi, and the PvPI Patient Connect Award to Mr. Delli Kumar T. from Vikruthamala, Chittoor District, Andhra Pradesh.
Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, Prof. Y. K. Gupta, National Scientific Advisor, Pharmacovigilance Programme of India (PvPI), Dr. Nilima Kshirsagar, Former National Chair ICMR, Government. of India VC, MUHS, Government of Maharashtra and Dr. Jai Prakash, Senior Principal Scientific Officer Officer-in-Charge PvPI IPC were present at the occasion.
Key Entities Referenced
Indian Pharmacopoeia Commission: The Indian Pharmacopoeia Commission (IPC) functions as the National Coordination Centre for the Pharmacovigilance Programme of India (NCCPvPI).
Pharmacovigilance Programme of India: A national program focused on monitoring and reporting adverse drug reactions (ADRs).
Dr. Rajeev Singh Raghuvanshi: Drugs Controller General of India (DCGI). He delivered the keynote address at the 5th National Pharmacovigilance Week.
New Delhi: The location where the 5th National Pharmacovigilance Week was inaugurated at the Bharat Mandapam Convention Centre.
National Pharmacovigilance Week: An annual event to sensitize healthcare professionals, regulators, researchers, and the public to actively report adverse drug reactions (ADRs).
Drugs Controller General of India: The head of the Central Drugs Standard Control Organization (CDSCO) in India, responsible for regulating pharmaceuticals and medical devices.
ADR Monitoring Centre, Mahamana Pandit Madan Mohan Malviya Cancer Centre, Varanasi, Uttar Pradesh: Recipient of the PvPI Patient Safety Excellence Award for its efforts in preventing adverse drug reactions.
Delli Kumar T., Vikruthamala, Chittoor District, Andhra Pradesh: Recipient of the PvPI Patient Connect Award for his active role and commitment in ADR reporting.
Ministry of Health and Family Welfare
Indian Pharmacopoeia Commission inaugurates 5th
National Pharmacovigilance Week with focus on
patient safety and ADR reporting
India Ranks Among Top Global Contributors in
Adverse Event Reporting: DCGI
“IPC and IP Successfully Placed at the Forefront of
India’s National Agenda”: Dr. Rajeev Singh
Raghuvanshi, DCGI
IPC Launches Key Initiatives to Enhance
Pharmacovigilance Awareness and Reporting
Mechanisms
Posted On: 17 SEP 2025 3:50PM by PIB Delhi
The Indian Pharmacopoeia Commission (IPC), functioning as the National Coordination Centre for the
Pharmacovigilance Programme of India (NCC-PvPI), inaugurated the 5th National Pharmacovigilance Week
(NPW) at the Bharat Mandapam Convention Centre, New Delhi. National Pharmacovigilance Week is being
observed from 17th–23rd September 2025 under the theme “Your Safety, Just a Click Away: Report to PvPI”.
The week-long campaign aims to sensitize healthcare professionals, regulators, researchers, and the public to
actively report adverse drug reactions (ADRs) through simplified digital platforms.Delivering the keynote address, Dr. Rajeev Singh Raghuvanshi, Drugs Controller General of India (DCGI),
highlighted the growing role of pharmacovigilance in safeguarding patient health. “Initiation of National
Pharmacovigilance Week in the journey of Pharmacovigilance in the country has changed the course of
Pharmacovigilance” Dr. Raghuvanshi said while addressing the gathering. “With the number of reporting, we
ranked among the top contributors globally in reporting adverse events”, he added.
Highlighting the significance of Pharmacovigilance, Dr. Rajeev Singh Raghuvanshi emphasized that ‘since
the inception of the programme, the majority of reports have come from healthcare professionals, whereas
meaningful impact can only be achieved when patients themselves actively participate in reporting’. He
further added that, despite the availability of significant data for analysis, its optimum utilisation in
strengthening Pharmacovigilance is still lacking.
Furthermore, he also stated that “the content of Pharmacovigilance needs to be changed as the context haschanged in the country. It is now that pharmacovigilance has got a strong base and policies are being designed
and regulated”
He also emphasized that, ‘We need to develop a culture of curiosity within organisation, not the culture of
apprehension, for better results.” “What is needed is the smart integration of technology and innovative
approaches to drive differential thinking.” he further added.
Underlining the strides made in the direction of Pharmacovigilance, Dr. Raghuvanshi stated that, “We have
been successful in bringing IPC and IP at the highest agenda of this country.”
On this occasion, IPC unveiled a series of new initiatives, including the launch of a short film on PvPI, a
pharmacovigilance comic published in multiple vernacular languages to enhance public awareness, and a new
online reporting platform designed for easy access through a QR code.
As part of the event, Dr. Rajeev Singh Raghuvanshi also presented awards to recognize outstanding
contributions in the field of pharmacovigilance. The PvPI – Patient Safety Excellence Award was conferred
upon the ADR Monitoring Centre at Mahamana Pandit Madan Mohan Malviya Cancer Centre, Varanasi, for
its exemplary efforts in preventing adverse drug reactions (ADRs). Additionally, the PvPI – Patient Connect
Award was presented to Mr. Delli Kumar T. from Vikruthamala, Chittoor District, Andhra Pradesh, for his
active role and commitment in ADR reporting, underscoring the crucial role of patient participation in
strengthening pharmacovigilance.Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, Prof. Y. K. Gupta, National Scientific Advisor,
Pharmacovigilance Programme of India(PvPI), Dr. Nilima Kshirsagar, Former National Chair – ICMR,
Government. of India & VC, MUHS, Government of Maharashtra and Dr. Jai Prakash, Senior Principal
Scientific Officer & Officer-in-Charge PvPI – IPC were present at the occasion.
*****
MV
th
HFW-Inaugural Ceremony of 5 NPW/17Sept2025/1
(Release ID: 2167578)